Screening for supra-additive effects of cytotoxic drugs and gamma irradiation in an in vitro model for hepatocellular carcinoma

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 2, 2004, Pages 146-152

  Lambert, B ^a   De Ridder, L ^b   Slegers, G ^b   De Gelder, V ^b   Dierckx, R A ^a   Thierens, H ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

5 fluorouracil; Cisplatin; Gamma irradiation; Gemcitabine; Hepatocellular carcinoma

Indexed keywords

CISPLATIN; CYTOTOXIC AGENT; FLUOROURACIL; GEMCITABINE;

ADDITION REACTION; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SCREENING; EXPERIMENTAL TEST; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER FUNCTION; PRIORITY JOURNAL; TUMOR SPHEROID;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CISPLATIN; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUOROURACIL; GAMMA RAYS; HUMANS; LIVER NEOPLASMS; RADIATION-SENSITIZING AGENTS; SPHEROIDS, CELLULAR; TIME FACTORS;

EID: 2042435766     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-008     Document Type: Conference Paper

References (22)

1. Aguayo, A., and Patt, Y.Z. 2001. Non surgical treatment of hepatocellular carcinoma. Sem. Oncol. 28: 503-513.
2. Brans, B., Van Laere, K., Gemmel, F., Defreyne, L., Van Langenhove, P., Troisi, R., Van Vlierberghe, H., Colle, I., de Hemptinne, B., and Dierckx, R.A. 2002. Combining iodine-131 Lipiodol therapy with low dose cisplatin as a radiosensitizer: preliminary results in hepatocellular carcinoma. Eur. J. Nucl. Med. Mol. Imaging, 29: 928-932.
3. Castañeda, F., and Kinne, R.K. 2000. Short exposure to millimolar concentrations of ethanol induces cell death in multicellular HepG2 spheroids. J. Cancer Res. Clin. Oncol. 126: 305-310.
4. Chenouffi, N., Raoul, J.L., Lescoat, G., Brissot, P., and Bourguet, P. 1998. In vitro demonstration of synergy between radionuclide and chemotherapy. J. Nucl. Med. 39: 900-903.
5. Chignola, R., Schenetti, A., Chiesa, E., Foroni, R., Sartoris, S., Brendolan, A., Tridente, G., Andrighetto, G., and Liberati, D. 1999. Oscillating growth patterns of multicellular tumour spheroids. Cell Prolif. 32: 39-48.
6. Giovannini, M., Elias, D., Monges, G., Raoul, J.L., and Rougier, P. 2001. Hepatocellular Carcinoma. Br. J. Cancer, 84: 74-77.
7. Ho, S., Lau, W.Y., Leung, T.W., and Johnson, P.J. 1998. Internal radiation therapy for patients with primary or metastatic hepatic cancer. Cancer, 83: 1894-1907.
8. Kashef, E., and Roberts, J.P. 2001. Transplantation for hepatocellular carcinoma. Semin. Oncol. 28: 497-502.
9. Lawrence, T.S., Eisbruch, A., and Shewach, D.S. 1997. gemcitabine-mediated radiosensitization. Sem. Oncol. 24: S7 24-28.
10. Leung, T.W., and Johnson, P.J. 2001. Systemic therapy for hepatocellular carinoma. Sem. Oncol. 28: 514-520.
11. Llovet, J.M., Real, M.I., Montana, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., and Bruix, J. 2002. Arterial embolisation or chemo-embolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma. A randomised controlled trial. Lancet, 3ε59: 1734-1739.
12. Maeda, H. 2001. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 46: 169-185.
13. Monto, A., and Wright, T.L. 2001. The epidemiology and prevention of hepatocellular carcinoma. Sem. Oncol. 28: 441-449.
14. Novell, J.R., and Hilson, A.J. 1994. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting. J. Nucl. Med. 35: 1318-1320.
15. Qian, J., Feng, G.S., and Vogl, T. 2003. Combined interventional therapies of hepatocellular carcinoma. World J. Gastroenterol. 9: 1885-1891.
16. Raoul, J.L., Guyader, D., Bretagne, J.F., Heautot, J.F., Duveaufertier, R., Bourguet, P., Bekhechi, D., Deugnier, Y.M., and Gosselin, M. 1997. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131-I-Iodized oil in the treatment of hepatocellular carcinoma. Hepatology, 26: 1156-1161.
17. Santini, M.T., Rainaldi, G., and Indovina, P.L. 1999. Multicellular tumour spheroids in radiation biology. Int. J. Radiat. Biol. 75: 787-799.
18. Schafer, D.F., and Sorrell, M.D. 1999. Hepatocellular carcinoma. Lancet, 353: 1253-1257.
19. Sutherland, R.M. 1988. Cell and environment interactions in tumor microregions. The multicellular spheroid model. Science (Washington, D.C.), 240: 177-184.
20. Ulrich-Pur, H., Kornek, G.V., Fiebiger, W., Schull, B., Raderer, M., and Scheithauer, W. 2001. Treatment of advanced hepatocellular carcinoma with bi-weekly high-dose gemcitabine. Oncology, 60: 312-315.
21. Yi, S.W., Kim, Y.H., Kwon, I.C., Chung, J.W., Park, J.H., Choi, Y.W., and Jeong, S.Y. 1998. Stable lipiodolized emulsions for hepatoma targeting and treatment by transcatheter arterial chemoembolisation. J. Control. Release, 50: 135-143.
22. Yoon, C.J., Chung, J.W., Park, J.H., Yoon, Y.H., Lee, J.W., Jeong, S.Y., and Chung, H. 2003. Transcatheter arterial chemoembolisation with paclitaxel-lipiodol solution in rabbit VX liver tumor. Radiology, 229: 126-131.